This paper is only available as a PDF. To read, Please Download here.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Clinical TherapeuticsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Efficacy and tolerability of IV doripenem versus meropenem in adults with complicated intra-abdominal infection: A phase III, prospective, multicenter, randomized, double-blind, noninferiority study.Clin Ther. 2008; 30: 868-883
- Merrem IV (Meropenem) [package insert]. AstraZeneca, Wilmington, DE2007
- Comparison of the pharmacodynamics of meropenem in healthy volunteers following administration by intermittent infusion or bolus injection.J Antimicrob Chemother. 2003; 52: 518-521
- Pharmacodynamics of antimicrobials for the empirical treatment of nosocomial pneumonia: A report from the OPTAMA program.Crit Care Med. 2005; 33: 2222-2227
- Efficacy and safety of intravenous infusion of doripenem versus imipenem in ventilator-associated pneumonia: A multicenter, randomized study.Crit Care Med. 2008; 36: 1089-1096
- Primaxin IV (imipenem/cilastatin) [package insert]. Merck, Whitehouse Station, NJ2007
Article info
Identification
Copyright
© 2008 Excerpta Medica Inc. All rights reserved. Published by Elsevier Inc.
